Cargando…

Pioglitazone Improves the Function of Human Mesenchymal Stem Cells in Chronic Kidney Disease Patients

Mesenchymal stem cells (MSCs) are optimal sources of autologous stem cells for cell-based therapy in chronic kidney disease (CKD). However, CKD-associated pathophysiological conditions, such as endoplasmic reticulum (ER) stress and oxidative stress, decrease MSC function. In this work, we study the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoon, Yeo Min, Lee, Jun Hee, Yun, Chul Won, Lee, Sang Hun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6540009/ https://www.ncbi.nlm.nih.gov/pubmed/31083336 http://dx.doi.org/10.3390/ijms20092314

Ejemplares similares

Exosomes isolated from melatonin-stimulated mesenchymal stem cells improve kidney function by regulating inflammation and fibrosis in a chronic kidney disease mouse model
por: Yea, Ji-Hye, et al.
Publicado: (2021)

Pioglitazone Protects Mesenchymal Stem Cells against P-Cresol-Induced Mitochondrial Dysfunction via Up-Regulation of PINK-1
por: Yoon, Yeo Min, et al.
Publicado: (2018)

TUDCA-Treated Mesenchymal Stem Cells Protect against ER Stress in the Hippocampus of a Murine Chronic Kidney Disease Model
por: Lee, Jun Hee, et al.
Publicado: (2019)

Hypoxia-induced expression of cellular prion protein improves the therapeutic potential of mesenchymal stem cells
por: Han, Yong-Seok, et al.
Publicado: (2016)

Potential and Therapeutic Efficacy of Cell-based Therapy Using Mesenchymal Stem Cells for Acute/chronic Kidney Disease
por: Yun, Chul Won, et al.
Publicado: (2019)

TUDCA-treated chronic kidney disease-derived hMSCs improve therapeutic efficacy in ischemic disease via PrP(C)
por: Yoon, Yeo Min, et al.
Publicado: (2019)

Co-Administration of Melatonin Effectively Enhances the Therapeutic Effects of Pioglitazone on Mesenchymal Stem Cells Undergoing Indoxyl Sulfate-Induced Senescence through Modulation of Cellular Prion Protein Expression
por: Han, Yong Seok, et al.
Publicado: (2018)

Antioxidant effects of Cirsium setidens extract on oxidative stress in human mesenchymal stem cells
por: Lee, Jun Hee, et al.
Publicado: (2016)

Hypoxic Preconditioning Promotes the Bioactivities of Mesenchymal Stem Cells via the HIF-1α-GRP78-Akt Axis
por: Lee, Jun Hee, et al.
Publicado: (2017)

Melatonin Protects Chronic Kidney Disease Mesenchymal Stem/Stromal Cells against Accumulation of Methylglyoxal via Modulation of Hexokinase-2 Expression
por: Go, Gyeongyun, et al.
Publicado: (2022)

Role of hypoxia-mediated cellular prion protein functional change in stem cells and potential application in angiogenesis
por: Yun, Seung Pil, et al.
Publicado: (2017)

Enhancement of Functionality and Therapeutic Efficacy of Cell-Based Therapy Using Mesenchymal Stem Cells for Cardiovascular Disease
por: Yun, Chul Won, et al.
Publicado: (2019)

Fucoidan Rescues p-Cresol-Induced Cellular Senescence in Mesenchymal Stem Cells via FAK-Akt-TWIST Axis
por: Lee, Jun Hee, et al.
Publicado: (2018)

Cripto Enhances Proliferation and Survival of Mesenchymal Stem Cells by Up-Regulating JAK2/STAT3 Pathway in a GRP78-Dependent Manner
por: Yun, SeungPil, et al.
Publicado: (2018)

Melatonin suppresses senescence‐derived mitochondrial dysfunction in mesenchymal stem cells via the HSPA1L–mitophagy pathway
por: Lee, Jun Hee, et al.
Publicado: (2020)

Melatonin Enhances Mitophagy by Upregulating Expression of Heat Shock 70 kDa Protein 1L in Human Mesenchymal Stem Cells under Oxidative Stress
por: Yoon, Yeo Min, et al.
Publicado: (2019)

Erratum to "Cripto Enhances Proliferation and Survival of Mesenchymal Stem Cells by Up-Regulating JAK2/STAT3 Pathway in a GRP78-Dependent Manner" [Biomol. Ther. 26 (2018) 464-473]
por: Yun, SeungPil, et al.
Publicado: (2021)

Pretreatment with Lycopene Attenuates Oxidative Stress-Induced Apoptosis in Human Mesenchymal Stem Cells
por: Kim, Ji Yong, et al.
Publicado: (2015)

Melatonin protects mesenchymal stem cells from autophagy‐mediated death under ischaemic ER‐stress conditions by increasing prion protein expression
por: Lee, Jun Hee, et al.
Publicado: (2018)

Pioglitazone-Primed Mesenchymal Stem Cells Stimulate Cell Proliferation, Collagen Synthesis and Matrix Gene Expression in Tenocytes
por: Kim, Won, et al.
Publicado: (2019)

Melatonin-Induced PGC-1α Improves Angiogenic Potential of Mesenchymal Stem Cells in Hindlimb Ischemia
por: Lee, Jun Hee, et al.
Publicado: (2020)

Melatonin Suppresses Renal Cortical Fibrosis by Inhibiting Cytoskeleton Reorganization and Mitochondrial Dysfunction through Regulation of miR-4516
por: Yoon, Yeo Min, et al.
Publicado: (2020)

Effect of Pioglitazone on Excitotoxic Neuronal Damage in the Mouse Hippocampus
por: Lee, Choong Hyun, et al.
Publicado: (2015)

Pioglitazone treatment prior to transplantation improves the efficacy of human mesenchymal stem cells after traumatic brain injury in rats
por: Das, Mahasweta, et al.
Publicado: (2019)

Pioglitazone Protects Compression-Mediated Apoptosis in Nucleus Pulposus Mesenchymal Stem Cells by Suppressing Oxidative Stress
por: Hu, Yiqiang, et al.
Publicado: (2019)

Pioglitazone in diabetic kidney disease: forgotten but not gone
por: Papaetis, Georgios S.
Publicado: (2022)

Melatonin Rescues Mesenchymal Stem Cells from Senescence Induced by the Uremic Toxin p-Cresol via Inhibiting mTOR-Dependent Autophagy
por: Yun, Seung Pil, et al.
Publicado: (2018)

Potential Therapeutic Strategy in Chronic Obstructive Pulmonary Disease Using Pioglitazone-Augmented Wharton's Jelly-Derived Mesenchymal Stem Cells
por: Park, Jin-Soo, et al.
Publicado: (2019)

Erratum to "Melatonin-Induced PGC-1α Improves Angiogenic Potential of Mesenchymal Stem Cells in Hindlimb Ischemia" [Biomol. Ther. 28 (2020) 240-249]
por: Lee, Jun Hee, et al.
Publicado: (2021)

European Kidney Function Consortium Equation vs. Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) Refit Equations for Estimating Glomerular Filtration Rate: Comparison with CKD-EPI Equations in the Korean Population
por: Kim, Hanah, et al.
Publicado: (2022)

Safety and efficacy of low dose pioglitazone compared with standard dose pioglitazone in type 2 diabetes with chronic kidney disease: A randomized controlled trial
por: Satirapoj, Bancha, et al.
Publicado: (2018)

Pioglitazone Improves Left Ventricular Diastolic Function in Subjects With Diabetes
por: Clarke, Geoffrey D., et al.
Publicado: (2017)

Knockdown of CK2α reduces P-cresol-induced fibrosis in human renal proximal tubule epithelial cells via the downregulation of profilin-1
por: Yoon, Yeo Min, et al.
Publicado: (2020)

Pioglitazone Improves Mitochondrial Function in the Remnant Kidney and Protects against Renal Fibrosis in 5/6 Nephrectomized Rats
por: Sun, Li, et al.
Publicado: (2017)

The Association of Pioglitazone and Urinary Tract Disease in Type 2 Diabetic Taiwanese: Bladder Cancer and Chronic Kidney Disease
por: Lee, Mei-Yueh, et al.
Publicado: (2014)

The efficacy of pioglitazone for renal protection in diabetic kidney disease
por: Ho, Chao-Chung, et al.
Publicado: (2022)

Long-Duration Three-Dimensional Spheroid Culture Promotes Angiogenic Activities of Adipose-Derived Mesenchymal Stem Cells
por: Lee, Jun Hee, et al.
Publicado: (2016)

Melatonin Treatment Improves Renal Fibrosis via miR-4516/SIAH3/PINK1 Axis
por: Yoon, Yeo Min, et al.
Publicado: (2021)

Pharmacokinetic/Pharmacodynamic Interaction Between Evogliptin and Pioglitazone in Healthy Male Subjects
por: Hwang, Inyoung, et al.
Publicado: (2020)

Cellular Prion Protein Enhances Drug Resistance of Colorectal Cancer Cells via Regulation of a Survival Signal Pathway
por: Lee, Jun Hee, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_148kmq51he3kfrnsddobvt06jp